Table 3 Multivariate analysis of the total number of hospitalizations and bed-days.
From: Long-term hospitalisations in survivors of paediatric solid tumours in France
Number of hospitalizations | Number of bed-days | |
|---|---|---|
RR (95% CI) | RR (95% CI) | |
Intercept | 1.79 (1.66–1.93)*** | 0.93 (0.89–0.98)*** |
Women (Ref = Men) | 0.97 (0.95–0.99)*** | 1.29 (1.27–1.31)*** |
Age in 2006 | 0.99 (0.99–0.99)*** | 0.99 (0.98–0.99)*** |
Age at first cancer (Ref = 0–1) | ||
2–4 | 0.89 (0.86–0.93)*** | 1.38 (1.35–1.41)*** |
5–9 | 0.99 (0.94–1.03) | 1.33 (1.29–1.37)*** |
10–14 | 1.04 (0.99–1.11) | 1.23 (1.19–1.28)*** |
≥ 15 | 0.83 (0.77–0.9)*** | 1 (0.96–1.05) |
Year of diagnosis (Ref = > 1990) | ||
< 1970 | 1.05 (0.93–1.19) | 1.86 (1.73–2)*** |
1970–1979 | 1.32 (1.22–1.43)*** | 1.82 (1.74–1.9)*** |
1980–1989 | 1.34 (1.27–1.41)*** | 2.07 (2.01–2.13)*** |
First primary cancer type (Ref = Neuroblastoma) | ||
Other solid cancer | 1.39 (1.3–1.48)*** | 1.4 (1.34–1.47)*** |
Kidney tumors | 1.09 (1.04–1.14)*** | 0.98 (0.95–1.01) |
Lymphoma | 0.99 (0.94–1.04) | 0.98 (0.95–1.01) |
Soft tissue sarcomas | 0.97 (0.92–1.03) | 0.95 (0.91–0.98)*** |
Bone sarcomas | 1.01 (0.95–1.08) | 1.03 (0.99–1.07) |
Central nervous system tumor | 1.29 (1.22–1.36)*** | 1.97 (1.9–2.03)*** |
Gonadal/Germ cell tumours | 1.02 (0.96–1.1) | 1.39 (1.34–1.45)*** |
Thyroid tumor | 0.66 (0.56–0.78)*** | 0.73 (0.66–0.8)*** |
Retinoblastoma | 0.98 (0.92–1.04) | 1.59 (1.54–1.65)*** |
Treatment (Ref = No radiotherapy or chemotherapy) | ||
Chemotherapy | 1.62 (1.53–1.70)*** | 2.63 (2.53–2.74)*** |
Radiotherapy | 2.10 (1.98–2.22)*** | 2.72 (2.61–2.83)*** |
Radiotherapy and Chemotherapy | 2.60 (2.46–2.73)*** | 3.72 (3.58–3.86)*** |
